Consistent with these results, we found that higher E2F3 expression was positively correlated with large tumor size, high tumor grade, late tumor stage, and the presence of metastasis in patients with ESCC (Table 4). This evidence concerns the gene E2F3 and esophageal squamous cell carcinoma.